- Suchergebnis für K05119
Cookie-Einstellungen
Diese Website benutzt Cookies, die für den technischen Betrieb der Website erforderlich sind und stets gesetzt werden. Andere Cookies, die den Komfort bei Benutzung dieser Website erhöhen, der Direktwerbung dienen oder die Interaktion mit anderen Websites und sozialen Netzwerken vereinfachen sollen, werden nur mit Ihrer Zustimmung gesetzt.
Konfiguration
Technisch erforderlich
Diese Cookies sind für die Grundfunktionen des Shops notwendig.
"Alle Cookies ablehnen" Cookie
"Alle Cookies annehmen" Cookie
Ausgewählter Shop
CSRF-Token
Cookie-Einstellungen
FACT-Finder Tracking
Individuelle Preise
Kundenspezifisches Caching
Session
Währungswechsel
Komfortfunktionen
Diese Cookies werden genutzt um das Einkaufserlebnis noch ansprechender zu gestalten, beispielsweise für die Wiedererkennung des Besuchers.
Facebook-Seite in der rechten Blog - Sidebar anzeigen
Merkzettel
Statistik & Tracking
Endgeräteerkennung
Kauf- und Surfverhalten mit Google Tag Manager
Partnerprogramm
Zu "K05119" wurden 151 Artikel gefunden!
Filter schließen
Filtern nach:
Für die Filterung wurden keine Ergebnisse gefunden!
Artikelnummer: TGM-T3059-100mg
Description: ALK-IN-1 (AP26113) is a potent ALK inhibitor with IC50 of 0.62 nM in a cell-free assay, demonstrated ability overcome Crizotinib resistance mediated by a L1196M mutation. Phase 2. Target: ALK, EGFR, IGF-1R. Smiles: N(C1=C(P(C)(C)=O)C=CC=C1)C2=NC(NC3=C(OC)C=C(C=C3)N4CCC(N(C)C)CC4)=NC=C2Cl. References:...
Schlagworte: | AP26113, Brigatinib, AP26113-analog |
Anwendung: | ALK inhibitor |
CAS | 1197958-12-5 |
MW: | 529.01 D |
ab 42,00 €
Artikelnummer: TGM-T3550-100mg
Description: X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion proteins, and ALK point mutation variants. Inhibition...
Schlagworte: | X-396, Ensartinib |
Anwendung: | ALK inhibitor |
CAS | 1365267-27-1 |
MW: | 547.41 D |
ab 33,00 €
Artikelnummer: TGM-T3621-100mg
Description: Brigatinib (AP-26113) is a highly potent and selective inhibitor of ALK. Target: FLT, IGF-1R, EGFR, ROS, ALK. Smiles: COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N1CCN(C)CC1. References: Wei-Sheng Huang, et al. J Med Chem, 2016, 59(10):4948-4964.
Schlagworte: | AP-26113 |
Anwendung: | Targets anaplastic lymphoma kinase [EC:2.7.10.1] (ALK, CD246) |
CAS | 1197953-54-0 |
MW: | 584.09 D |
ab 33,00 €
Artikelnummer: TGM-T3041-100mg
Description: ALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase. Target: ALK, FAK. Smiles: CNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(cc2OC)N2CCN(C)CC2)ncc1Cl. References: A Dose Finding Study With Oral LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase...
Anwendung: | ALK inhibitor |
CAS | 761438-38-4 |
MW: | 518.03 D |
ab 119,00 €
Artikelnummer: TGM-T2655-1mg
Description: CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK). Target: FAK, ALK. Smiles: CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl. References: Iragavarapu C, et al. J Hematol Oncol. 2015 Feb 27,8(1):17.
Schlagworte: | CEP37440 |
Anwendung: | FAK1 & ALK inhibitor |
CAS | 1391712-60-9 |
MW: | 580.12 D |
ab 34,00 €
Artikelnummer: TGM-T37585-100mg
Description: Ensartinib (X-396) is a potent dual ALK/MET inhibitor with IC50 values of <0.4 nM for ALK and 0.74 nM for MET. Target: Others. Smiles: C(=O)(N1C[C@@H](C)N[C@@H](C)C1)C2=CC=C(NC(=O)C3=CC(O[C@H](C)C4=C(Cl)C(F)=CC=C4Cl)=C(N)N=N3)C=C2. References: Lovly CM, et al. Insights into ALK-driven cancers revealed...
Anwendung: | Targets anaplastic lymphoma kinase [EC:2.7.10.1] (ALK, CD246) |
CAS | 1370651-20-9 |
MW: | 561.44 D |
ab 1.822,00 €
Artikelnummer: TGM-T4015-100mg
Description: HG-14-10-04 is a potent and specific ALK (anaplastic lymphoma kinase) inhibitor. Target: ALK. Smiles: COc1cc(ccc1Nc1ncc(Cl)c(n1)-c1c[nH]c2ccccc12)N1CCC(CC1)N1CCN(C)CC1. References: U.S. Pat. Appl. Publ. (2012), US 20120028924 A1
Anwendung: | ALK inhibitor |
CAS | 1356962-34-9 |
MW: | 532.08 D |
ab 55,00 €
Artikelnummer: TGM-T8387-100mg
Description: Alectinib hydrochloride (RO5424802 Hydrochloride) is a selective, and orally available inhibitor of ALK( IC50 : 1.9 nM). Target: ALK. Smiles: Cl.CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1. References: Sakamoto H, et al. CH5424802, a selective ALK inhibitor capable of blocking the...
Schlagworte: | CH5424802 (Hydrochloride), RO5424802 (Hydrochloride), AF-802 (Hydrochloride) |
Anwendung: | Antineoplastic, Anaplastic lymphoma kinase (ALK) inhibitor |
CAS | 1256589-74-8 |
MW: | 519.08 D |
ab 39,00 €
Artikelnummer: TGM-TMPK-00927-100ug
Description: Anaplastic lymphoma kinase (ALK) is mostly known for its oncogenic role in several human cancers. Recent evidences clearly indicate new roles of ALK and its genetic aberrations (e.g. gene rearrangements and mutations) in immune evasion, innate and cell-mediated immunity. New ALK-related immunotherapy...
Schlagworte: | Anaplastic lymphoma kinase, ALK tyrosine kinase receptor, CD246 |
MW: | 101.11 kD |
ab 401,00 €
Artikelnummer: TGM-T1962-100mg
Description: ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS. Target: Apoptosis, ALK. Smiles:...
Schlagworte: | ASP 3026 |
Anwendung: | ALK / ACK inhibitor |
CAS | 1097917-15-1 |
MW: | 580.74 D |
ab 37,00 €
Artikelnummer: TGM-T2612-10mg
Description: CEP-28122 is a highly potent and selective, orally active ALK inhibitor. Target: ALK. Smiles: N([C@@H]1[C@@]2(C[C@]([C@@H]1C(N)=O)(C=C2)[H])[H])C3=NC(NC=4C(OC)=C5C(=CC4)CC[C@@H](CC5)N6CCOCC6)=NC=C3Cl. References: Abate F, et al. Leukemia. 2015 Jun,29(6):1390-401.
Anwendung: | ALK inhibitor |
CAS | 1022958-60-6 |
MW: | 539.07 D |
ab 52,00 €
Artikelnummer: TGM-T1936-100mg
Description: Alectinib (RG-7853) is an orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity. Target: Tyrosine Kinases, ALK, VEGFR. Smiles: CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1. References: Sakamoto H, et al. Cancer...
Schlagworte: | AF-802, CH5424802, AF802, RG-7853 |
Anwendung: | Targets anaplastic lymphoma kinase [EC:2.7.10.1] (ALK, CD246) |
CAS | 1256580-46-7 |
MW: | 482.62 D |
ab 41,00 €